All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Pharmacogenetics Journals

For ten-year-old leukemia tolerant Jason Saunders, the typical chemotherapy was not going to work. Given the standard medication treatment, there was a solid possibility that poisonous metabolites would develop in his body and make him debilitated, requiring a break in his treatment that would permit the disease to return. This is on the grounds that Jason is one of the 10% of Caucasians with a hereditary variety that decreases his capacity to process thiopurines, the medications most generally used to treat intense lymphoblastic leukemia. As opposed to having two high-movement duplicates of the TPMT quality that delivers the protein liable for utilizing these medications